Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · Real-Time Price · USD
15.72
-0.16 (-1.01%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Bausch + Lomb Revenue
In the year 2025, Bausch + Lomb had annual revenue of $5.10B with 6.47% growth. Bausch + Lomb had revenue of $2.45B in the quarter ending December 31, 2025, with 91.14% growth.
Revenue (ttm)
$5.78B
Revenue Growth
+29.08%
P/S Ratio
1.10
Revenue / Employee
$392,385
Employees
13,000
Market Cap
5.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.10B | 310.00M | 6.47% |
| Dec 31, 2024 | 4.79B | 645.00M | 15.56% |
| Dec 31, 2023 | 4.15B | 378.00M | 10.03% |
| Dec 31, 2022 | 3.77B | 3.00M | 0.08% |
| Dec 31, 2021 | 3.77B | 353.00M | 10.35% |
| Dec 31, 2020 | 3.41B | -366.00M | -9.69% |
| Dec 31, 2019 | 3.78B | 113.00M | 3.08% |
| Dec 31, 2018 | 3.67B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baxter International | 11.24B |
| Avantor | 6.55B |
| AptarGroup | 3.78B |
| MiniMed Group | 2.99B |
| Envista Holdings | 2.72B |
| ICU Medical | 2.23B |
| Teleflex | 1.99B |
| Merit Medical Systems | 1.52B |
BLCO News
- 6 days ago - Bausch + Lomb Releases 2025 Sustainability Impact Report - Business Wire
- 12 days ago - Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling Program - Business Wire
- 22 days ago - Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual Meeting - Business Wire
- 4 weeks ago - Bausch + Lomb Will Release First-Quarter 2026 Financial Results on April 29 - Business Wire
- 5 weeks ago - Bausch + Lomb Transcript: Status update - Transcripts
- 5 weeks ago - Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma - Business Wire
- 6 weeks ago - Bausch + Lomb Corporation Investigated by the Portnoy Law Firm - GlobeNewsWire
- 7 weeks ago - Bausch + Lomb Launches R&D “Teach-in” Webinar Series - Business Wire